Dihydroxyaluminum sodium carbonate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Dihydroxyaluminum sodium carbonate is a medication used to treat heartburn.

Generic Name
Dihydroxyaluminum sodium carbonate
DrugBank Accession Number
DB15825
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 143.993
Monoisotopic: 143.9615309
Chemical Formula
CH2AlNaO5
Synonyms
  • Aluminium-natrium-carbonat-dihydroxid
  • Aluminum sodium dihydroxide monocarbonate
  • Dihydroxo-aluminium-natrium-carbonat
  • Dihydroxyaluminum sodium carbonate

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Treatment ofHeartburn••••••••••••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
Chenodeoxycholic acidDihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Chenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cholic AcidDihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Cholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dehydrocholic acidDihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Dehydrocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deoxycholic acidDihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
DolutegravirThe serum concentration of Dolutegravir can be decreased when it is combined with Dihydroxyaluminum sodium carbonate.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
International/Other Brands
Daxaids / Noacid / Rolaids
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
ทิมมี่Tablet334 mgOralบริษัท บี.เอ็ล.ฮั้ว จำกัด จำกัด1987-02-18Not applicableThailand flag
ทิมมี่Tablet334 mgOralบริษัท บี.เอ็ล.ฮั้ว จำกัด จำกัด1987-02-18Not applicableThailand flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
84H8Z9550J
CAS number
16482-55-6
InChI Key
SEIGJEJVIMIXIU-UHFFFAOYSA-J
InChI
InChI=1S/CH2O3.Al.Na.2H2O/c2-1(3)4;;;;/h(H2,2,3,4);;;2*1H2/q;+3;+1;;/p-4
IUPAC Name
sodium dihydroxyalumanylium carbonate
SMILES
[Na+].O[Al+]O.[O-]C([O-])=O

References

General References
  1. TITCK Product Information: KOMPENSAN (Dihydroxyaluminum sodium carbonate) oral tablet [Link]
ChemSpider
7969582
RxNav
23163
ChEMBL
CHEMBL3707202
Wikipedia
Carbaldrate

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
TabletOral340 mg
TabletOral334 mg
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility269.0 mg/mLALOGPS
logP-0.71ALOGPS
logP0.25Chemaxon
logS0.27ALOGPS
pKa (Strongest Acidic)3.5Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area63.19 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity31.17 m3·mol-1Chemaxon
Polarizability3.52 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at September 11, 2020 17:56 / Updated at May 14, 2021 01:08